102 related articles for article (PubMed ID: 26691217)
1. Upregulation of cugbp2 increases response of pancreatic cancer cells to chemotherapy.
Jakstaite A; Maziukiene A; Silkuniene G; Kmieliute K; Dauksa A; Paskauskas S; Gulbinas A; Dambrauskas Z
Langenbecks Arch Surg; 2016 Feb; 401(1):99-111. PubMed ID: 26691217
[TBL] [Abstract][Full Text] [Related]
2. HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer.
Jakstaite A; Maziukiene A; Silkuniene G; Kmieliute K; Gulbinas A; Dambrauskas Z
World J Gastroenterol; 2015 Dec; 21(46):13004-19. PubMed ID: 26675757
[TBL] [Abstract][Full Text] [Related]
3. RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells.
Subramaniam D; Ramalingam S; Linehan DC; Dieckgraefe BK; Postier RG; Houchen CW; Jensen RA; Anant S
PLoS One; 2011 Feb; 6(2):e16958. PubMed ID: 21347286
[TBL] [Abstract][Full Text] [Related]
4. CUGBP2 plays a critical role in apoptosis of breast cancer cells in response to genotoxic injury.
Mukhopadhyay D; Jung J; Murmu N; Houchen CW; Dieckgraefe BK; Anant S
Ann N Y Acad Sci; 2003 Dec; 1010():504-9. PubMed ID: 15033780
[TBL] [Abstract][Full Text] [Related]
5. Functional antagonism between RNA binding proteins HuR and CUGBP2 determines the fate of COX-2 mRNA translation.
Sureban SM; Murmu N; Rodriguez P; May R; Maheshwari R; Dieckgraefe BK; Houchen CW; Anant S
Gastroenterology; 2007 Mar; 132(3):1055-65. PubMed ID: 17383427
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment.
Berberat PO; Dambrauskas Z; Gulbinas A; Giese T; Giese N; Künzli B; Autschbach F; Meuer S; Büchler MW; Friess H
Clin Cancer Res; 2005 May; 11(10):3790-8. PubMed ID: 15897578
[TBL] [Abstract][Full Text] [Related]
7. Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2.
Subramaniam D; Natarajan G; Ramalingam S; Ramachandran I; May R; Queimado L; Houchen CW; Anant S
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G1025-32. PubMed ID: 18292181
[TBL] [Abstract][Full Text] [Related]
8. Dynamic antagonism between RNA-binding protein CUGBP2 and cyclooxygenase-2-mediated prostaglandin E2 in radiation damage.
Murmu N; Jung J; Mukhopadhyay D; Houchen CW; Riehl TE; Stenson WF; Morrison AR; Arumugam T; Dieckgraefe BK; Anant S
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13873-8. PubMed ID: 15358864
[TBL] [Abstract][Full Text] [Related]
9. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2.
Mukhopadhyay D; Houchen CW; Kennedy S; Dieckgraefe BK; Anant S
Mol Cell; 2003 Jan; 11(1):113-26. PubMed ID: 12535526
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor-induced stabilization of cyclooxygenase 2 mRNA in rat smooth muscle cells requires the c-Src family of protein-tyrosine kinases.
Xu K; Kitchen CM; Shu HK; Murphy TJ
J Biol Chem; 2007 Nov; 282(45):32699-709. PubMed ID: 17855367
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of heme oxygenase-1 enhances the chemosensitivity and suppresses the proliferation of pancreatic cancer cells through the SHH signaling pathway.
Han L; Jiang J; Ma Q; Wu Z; Wang Z
Int J Oncol; 2018 Jun; 52(6):2101-2109. PubMed ID: 29620188
[TBL] [Abstract][Full Text] [Related]
12. Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer.
Noma B; Sasaki T; Fujimoto Y; Serikawa M; Kobayashi K; Inoue M; Itsuki H; Kamigaki M; Minami T; Chayama K
Int J Oncol; 2008 Dec; 33(6):1187-94. PubMed ID: 19020751
[TBL] [Abstract][Full Text] [Related]
13. The Role of
Pauzas H; Gyvyte U; Latkauskas T; Kairevice L; Lizdenis P; Svagzdys S; Birgiolaite E; Kuliaviene I; Kupcinskas J; Tamelis A
Medicina (Kaunas); 2020 Apr; 56(4):. PubMed ID: 32331433
[No Abstract] [Full Text] [Related]
14. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
[TBL] [Abstract][Full Text] [Related]
15. Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo.
Nuhn P; Künzli BM; Hennig R; Mitkus T; Ramanauskas T; Nobiling R; Meuer SC; Friess H; Berberat PO
Mol Cancer; 2009 Jun; 8():37. PubMed ID: 19508729
[TBL] [Abstract][Full Text] [Related]
16. Novel intestinal splice variants of RNA-binding protein CUGBP2: isoform-specific effects on mitotic catastrophe.
Ramalingam S; Natarajan G; Schafer C; Subramaniam D; May R; Ramachandran I; Queimado L; Houchen CW; Anant S
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G971-81. PubMed ID: 18258790
[TBL] [Abstract][Full Text] [Related]
17. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
18. Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer.
Nath S; Roy LD; Grover P; Rao S; Mukherjee P
Pancreas; 2015 Aug; 44(6):909-17. PubMed ID: 26035123
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2.
Fan B; Jiao BH; Fan FS; Lu SK; Song J; Guo CY; Yang JK; Yang L
Int J Oncol; 2015 Sep; 47(3):1025-33. PubMed ID: 26165303
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.
Xiao Z; Ding N; Xiao G; Wang S; Wu Y; Tang L
Anat Rec (Hoboken); 2012 Dec; 295(12):2122-8. PubMed ID: 22907845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
